Table 1.
Chemical | Administration | Target organ | Histology | Genetic/epigenetic alteration | Other characteristics |
---|---|---|---|---|---|
Ferric nitrilotriacetate32 | Intraperitoneal | Kidney (proximal tubular cells) | Renal cell carcinoma | HD/RM of Cdkn2a/2b; Met amplification,42 OE of Annexin 260 and miR-34a61 | 1–2 years for induction; male preference |
Ferric saccharate, with nitrilotriacetate19 | Intraperitoneal | Mesothelium (mesothelial cells) | Malignant mesothelioma | HD of Cdkn2a/2b only in sarcomatoid subtype28 | >2 years for induction; low incidence; strict male preference |
Asbestos (chrysotile, crocidolite, Amosite), with nitrilotriacetate24 | Intraperitoneal | Mesothelium (mesothelial cells) | Malignant mesothelioma | HD of Cdkn2a/2b | 1–2 years for induction; extremely high incidence; no sex preference |
HD, homozygous deletion; OE, overexpression; RM, repression by methylation of the promoter region.